PPD offers a broad range of early development services, Phase I clinical trial services and nonclinical consulting.
Experience across a broad range of indications and an investigator network of more than 6,000 cardiologists.
PPD's Phase I Clinic conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers.
PPD News and Events Media kit
Senior Vice President, Site and Patient Access
Adaptive trial designs are gaining increased interest both from drug developers and regulators as a means for improving clinical trial efficiencies.
Niklas Morton, vice president of global biostatistics and programming for PPD, discusses the drivers behind the growth in adaptive design, its future potential and how regulators view this burgeoning methodology.
For more information on adaptive trial design, download an executive summary of this podcast, or download a copy of our most recent white paper.
We want to hear from you
Register in PPD's Database
© 2018 Pharmaceutical Product Development, LLC. All rights reserved.